Preliminary findings of a phase I dose-escalation study of sunitinib in combination with gemcitabine plus cisplatin in advanced non-small cell lung cancer (NSCLC)

被引：0
作者：
Reck, M. [1 ]
Frickhofen, N. [2 ]
Gatzemeier, U. [1 ]
Fuhr, H. G. [2 ]
Lanzalone, S. [3 ]
Wang, E. [4 ]
Chao, R. [4 ]
Felip, E. [5 ]
机构：
[1] Hosp Grosshansdorf, Dept Thorac Oncol, Grosshansdorf, Germany
[2] Dr Horst Schmidt Klin, Wiesbaden, Germany
[3] Pfizer Italia, Milan, Italy
[4] Pfizer Inc, Global Res & Dev, La Jolla, CA USA
[5] Vall Hebron Univ Hosp, Dept Oncol, Barcelona, Spain
来源：
EJC SUPPLEMENTS | 2007年 / 5卷 / 04期
关键词：
D O I：
10.1016/S1359-6349(07)71435-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6607
引用
收藏
页码：390 / 390
页数：1
相关论文
共 50 条
[31]   Phase I/II Study of Gemcitabine and Vinorelbine Plus Cisplatin in Non-Small Cell Lung Cancer [J].
Emilio Esteban ;
Joaquín Fra ;
Marian Sala ;
Juan Carrasco ;
Norberto Corral ;
José María Vieitez ;
Enrique Estrada ;
Isabel Palacio ;
José Marí Buesa ;
Angel J. Lacave .
Investigational New Drugs, 2002, 20 :317-326
[32]   Phase I dose-escalation study of sorafenib in combination with bevacizumab (B), paclitaxel (P), and carboplatin (C) for the treatment of advanced nonsquamous non-small cell lung cancer (NSCLC). [J].
Blumenschein, G. R. ;
Molina, J. R. ;
Lathia, C. D. ;
Ong, T. J. ;
Roth, D. ;
Rajagopalan, P. ;
Fossella, F. V. ;
Kies, M. S. ;
Marks, R. S. ;
Adjei, A. A. ;
Sundaresan, P. R. .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
[33]   Gemcitabine plus cisplatin in non-small cell lung cancer: A Phase II study [J].
Sandler, A ;
Ansari, R ;
McClean, J ;
Fisher, W ;
Dorr, FA ;
Einhorn, LH .
EUROPEAN JOURNAL OF CANCER, 1995, 31A :1079-1079
[34]   Cisplatin, Gemcitabine and paclitaxel in advanced non-small cell lung cancer. A phase I study [J].
Comella, P ;
Frasci, G ;
Panza, N ;
Lorusso, V ;
Nicolella, GP ;
Natale, M ;
Manzione, L ;
Bilancia, D ;
Cioffi, R ;
Maiorino, L ;
Apicella, A ;
Gravina, A ;
Ruffolo, P ;
De Rosa, V ;
Comella, G .
ANNALS OF ONCOLOGY, 1998, 9 :91-91
[35]   Results of high dose of gemcitabine plus cisplatin combination in metastatic non-small cell lung cancer [J].
Mayadagli, A ;
Cepni, K ;
Ozkan, A ;
Ozseker, N ;
Tepetam, H .
LUNG CANCER, 2005, 49 :S258-S258
[36]   A dose-escalation study of vorinostat in combination with radiotherapy for patients with non-small cell lung cancer [J].
Decker, R. H. ;
Gettinger, S. N. ;
Wilson, L. D. .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[37]   Gemcitabine plus cisplatin in the treatment of patients with advanced non-small cell lung cancer: A phase II study [J].
Bretti, S ;
Manzin, E ;
Loddo, C ;
Berruti, A ;
Bombaci, S ;
Vellani, G ;
Celano, A .
ANTICANCER RESEARCH, 2002, 22 (05) :3039-3043
[38]   Phase III study of pemetrexed plus cisplatin versus gemcitabine plus cisplatin in chemonaive patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) [J].
Manegold, C. ;
Digumarti, R. ;
Zukin, M. ;
de Marinis, F. ;
Mellerngaard, A. ;
Gandara, D. ;
Simms, L. ;
Kaiser, C. ;
Blatter, J. ;
Gatzemeier, U. .
EJC SUPPLEMENTS, 2007, 5 (06) :9-9
[39]   Phase III study of pemetrexed plus cisplatin versus gemcitabine plus cisplatin in chemonaive patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) [J].
Scagliotti, Giorgio ;
Purvish, Parikh ;
von Pawel, Joachim ;
Biesma, Bonna ;
Vansteenkiste, Johan ;
Manegold, Christian ;
Simms, Lorinda ;
Posther, Sugarman Katherine ;
Obasaju, Coleman ;
Blatter, Johannes .
JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) :S306-S306
[40]   A Phase I Dose-Escalation Study of Lenalidomide in Combination with Gemcitabine in Patients with Advanced Pancreatic Cancer [J].
Ullenhag, Gustav J. ;
Rossmann, Eva ;
Liljefors, Maria .
PLOS ONE, 2015, 10 (04)
12345